These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26773714)

  • 1. Comparison of corneal degeneration and calcific band keratopathy from 2000 to 2013 in 69 horses.
    Berryhill EH; Thomasy SM; Kass PH; Reilly CM; Good KL; Hollingsworth SR; Maggs DJ; Magdesian KG; Pusterla N
    Vet Ophthalmol; 2017 Jan; 20(1):16-26. PubMed ID: 26773714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory stromal keratopathies: medical management of stromal keratomalacia, stromal abscesses, eosinophilic keratitis, and band keratopathy in the horse.
    Brooks DE
    Vet Clin North Am Equine Pract; 2004 Aug; 20(2):345-60, vi. PubMed ID: 15271427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diamond burr debridement of calcific band keratopathy in 24 eyes of 22 horses.
    Jugant S; Regnier A; Douet JY
    Vet Ophthalmol; 2024 Mar; ():. PubMed ID: 38529825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcific band keratopathy in an alpaca.
    Pucket JD; Boileau MJ; Sula MJ
    Vet Ophthalmol; 2014 Jul; 17(4):286-9. PubMed ID: 23998709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and impact of equine recurrent uveitis.
    Gerding JC; Gilger BC
    Equine Vet J; 2016 May; 48(3):290-8. PubMed ID: 25891653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDTA chelation for calcific band keratopathy: results and long-term follow-up.
    Najjar DM; Cohen EJ; Rapuano CJ; Laibson PR
    Am J Ophthalmol; 2004 Jun; 137(6):1056-64. PubMed ID: 15183790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraocular lymphoma in the horse.
    Schnoke AT; Brooks DE; Wilkie DA; Dwyer AE; Matthews AG; Gilger BC; Hendrix DV; Pickett P; Grauwels M; Monroe C; Plummer CE
    Vet Ophthalmol; 2013 Jan; 16(1):35-42. PubMed ID: 22500697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcome and ocular survival following iris prolapse in the horse: a review of 32 cases.
    Chmielewski NT; Brooks DE; Smith PJ; Hendrix DV; Whittaker C; Gelatt KN
    Equine Vet J; 1997 Jan; 29(1):31-9. PubMed ID: 9031861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine keratomycoses in California from 1987 to 2010 (47 cases).
    Reed Z; Thomasy SM; Good KL; Maggs DJ; Magdesian KG; Pusterla N; Hollingsworth SR
    Equine Vet J; 2013 May; 45(3):361-6. PubMed ID: 22943420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of calcific band keratopathy without ethylenediaminetetraacetic acid (EDTA) in eyes with limited visual potential.
    Bee CR; Koenig LR; Hwang ES; Koenig SB
    Clin Ophthalmol; 2018; 12():1895-1899. PubMed ID: 30319241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic frequency, response to therapy, and long-term prognosis among horses and ponies with pituitary par intermedia dysfunction, 1993-2004.
    Rohrbach BW; Stafford JR; Clermont RS; Reed SM; Schott HC; Andrews FM
    J Vet Intern Med; 2012; 26(4):1027-34. PubMed ID: 22524260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis.
    Ollivier FJ; Brooks DE; Van Setten GB; Schultz GS; Gelatt KN; Stevens GR; Blalock TD; Andrew SE; Komaromy AM; Lassaline ME; Kallberg ME; Cutler TJ
    Vet Ophthalmol; 2004; 7(6):397-405. PubMed ID: 15511281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effects of age and pituitary pars intermedia dysfunction on corneal sensitivity in horses.
    Miller C; Utter ML; Beech J
    Am J Vet Res; 2013 Jul; 74(7):1030-5. PubMed ID: 23802675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine deep stromal abscesses (51 cases - 2004-2009)--Part 1: the clinical aspects with attention to the duration of the corneal disease, treatment history, clinical appearance, and microbiology results.
    de Linde Henriksen M; Andersen PH; Thomsen PD; Plummer CE; Mangan B; Heegaard S; Toft N; Brooks DE
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():6-13. PubMed ID: 24131726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of equine corneal disease using spectral domain optical coherence tomography (SD-OCT).
    Blanchard A; Barr EM; Gilger BC
    Vet Ophthalmol; 2019 Nov; 22(6):791-798. PubMed ID: 30767400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal calcific band keratopathy.
    Jhanji V; Rapuano CJ; Vajpayee RB
    Curr Opin Ophthalmol; 2011 Jul; 22(4):283-9. PubMed ID: 21537183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses.
    McGowan TW; Pinchbeck GP; McGowan CM
    Equine Vet J; 2013 Jan; 45(1):74-9. PubMed ID: 22594955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of linear keratopathy in a herd of Lipizzaners over an 18-month period.
    Rushton JO; Tichy A; Kolodziejek J; Nowotny N; Nell B
    Vet Rec; 2013 Aug; 173(8):192. PubMed ID: 23839726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, histopathological and immunohistochemical characterization of a novel equine ocular disorder: heterochromic iridocyclitis with secondary keratitis in adult horses.
    Pinto NI; McMullen RJ; Linder KE; Cullen JM; Gilger BC
    Vet Ophthalmol; 2015 Nov; 18(6):443-56. PubMed ID: 25399915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suspensory ligament degeneration associated with pituitary pars intermedia dysfunction in horses.
    Hofberger S; Gauff F; Licka T
    Vet J; 2015 Mar; 203(3):348-50. PubMed ID: 25641552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.